Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Operating Cash Flow per Share : ¥-0.15 (TTM As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Jiangsu Wuzhong Pharmaceutical Development Co Operating Cash Flow per Share?

Jiangsu Wuzhong Pharmaceutical Development Co's operating cash flow per share for the three months ended in Mar. 2024 was ¥0.01. Jiangsu Wuzhong Pharmaceutical Development Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.15.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 21.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Jiangsu Wuzhong Pharmaceutical Development Co's Operating Cash Flow per Share or its related term are showing as below:

SHSE:600200' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -55 Med: 21.6 Max: 94.1
Current: 21.3

During the past 13 years, Jiangsu Wuzhong Pharmaceutical Development Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 94.10% per year. The lowest was -55.00% per year. And the median was 21.60% per year.

SHSE:600200's 3-Year OCF Growth Rate is ranked better than
69.96% of 1235 companies
in the Biotechnology industry
Industry Median: 3.3 vs SHSE:600200: 21.30

Jiangsu Wuzhong Pharmaceutical Development Co Operating Cash Flow per Share Historical Data

The historical data trend for Jiangsu Wuzhong Pharmaceutical Development Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Wuzhong Pharmaceutical Development Co Operating Cash Flow per Share Chart

Jiangsu Wuzhong Pharmaceutical Development Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.23

-0.58

0.59

0.08

-0.28

Jiangsu Wuzhong Pharmaceutical Development Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.11	-0.06	-0.22	0.12	0.01

Competitive Comparison of Jiangsu Wuzhong Pharmaceutical Development Co's Operating Cash Flow per Share

For the Biotechnology subindustry, Jiangsu Wuzhong Pharmaceutical Development Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jiangsu Wuzhong Pharmaceutical Development Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangsu Wuzhong Pharmaceutical Development Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Jiangsu Wuzhong Pharmaceutical Development Co's Price-to-Operating-Cash-Flow falls into.

Jiangsu Wuzhong Pharmaceutical Development Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Jiangsu Wuzhong Pharmaceutical Development Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-203.678	/	719.452
	=	-0.28

Jiangsu Wuzhong Pharmaceutical Development Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	6.523	/	722.730
	=	0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.15

Jiangsu Wuzhong Pharmaceutical Development Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Jiangsu Wuzhong Pharmaceutical Development Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Wuzhong Pharmaceutical Development Co Ltd (SHSE:600200) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

110 North Road, Soochow 7,8,10 Bank of China Building, Suzhou, Jiangsu, CHN, 215128

Website

http://www.600200.com

Jiangsu Wuzhong Industrial Co Ltd is a China-based company. It develops, produces and sells medicines while engages in real estate development.

Executives

Xu Liang Zhi	senior management
Sun Jian Ying	Supervisors
Zhong Yao Wen	Supervisors
Cheng Xi	senior management
Wu Jian Min	Supervisors
Zhao Wei Yi	Director
Jin Li	Director
Sun Tian Jiang	senior management
Zhu Ju Fang	senior management
Yao Jian Lin	Director
Jin Jian Ping	Supervisors
Li Gui Zhi	Supervisors
Luo Qin	Supervisors
Xia Jian Ping	Director
Zhong Shen Zheng	Director

Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Headlines

No Headlines